Car T News, Articles | The Scientist Magazine®

car-t

The Scientist Creative Services Team in collaboration with Thermo Fisher Scientific | Sep 7, 2021 | 2 min read

Automated counterflow centrifugation systems accelerate cell therapy workflow processes while maintaining cell yields and efficacy.

The Scientist’s Creative Services Team | Aug 27, 2020 | 1 min read

Download this eBook to take a closer look at past efforts, modern challenges, and future advances!

Katarina Zimmer | Jan 22, 2018 | 2 min read

Pharmaceutical giant Sanofi to take over hemophilia drugmaker Biovertiv, while Celgene will buy cancer drugmaker Juno Therapeutics.

Diana Kwon | Jun 5, 2017 | 2 min read

The results of two small clinical trials show that the immunotherapy is effective for multiple myeloma patients, at least in the near term.

Ben Andrew Henry | Sep 6, 2016 | 1 min read

The company has shuttered its experimental cell and gene cancer therapy unit, firing more than 100 researchers.

Kerry Grens | Jul 8, 2016 | 3 min read

Juno Therapeutics asks the US Food and Drug Administration for permission to restart the CAR-T experiments without chemotherapy.

Kerry Grens | Mar 16, 2016 | 2 min read

Corrections give belated credit for immunotherapy; mosquitoes have been bugging us long before Zika; the bright side of irreproducibility